Are there predictors that can determine neoadjuvant treatment responses in rectal cancer?

Rakici S., Bedir R., Hatipoglu C.

TURKISH JOURNAL OF GASTROENTEROLOGY, vol.30, no.3, pp.220-227, 2019 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 30 Issue: 3
  • Publication Date: 2019
  • Doi Number: 10.5152/tjg.2018.18179
  • Journal Name: TURKISH JOURNAL OF GASTROENTEROLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.220-227
  • Keywords: Rectal neoplasms, neoadjuvant treatment, DNA mismatch repair, microsatellite instability, P53 genes, neutrophil-lymphocyte ratio, PREOPERATIVE CHEMORADIOTHERAPY, COLORECTAL-CANCER, PATHOLOGICAL RESPONSE, MICROSATELLITE-INSTABILITY, LYMPHOCYTE RATIO, P53, EXPRESSION, RADIATION, SURGERY
  • Recep Tayyip Erdoğan University Affiliated: Yes

Abstract

Background/Aims: This study aimed to determine a predictive bioindicator that would detect the treatment response of patients diagnosed with rectal cancer and treated with neoadjuvant chemoradiotherapy (nCRT).